Login / Signup

Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood-tests during long-term treatment: cohort study using data from Clinical Practice Research Datalink Gold and Aurum.

Georgina NakaferoMatthew J GraingeTim CardMaarten W TaalGuruprasad P AithalWeiya ZhangMichael DohertyChristopher P FoxChristian D MallenAbhishek Abhishek
Published in: Rheumatology (Oxford, England) (2021)
We have developed and externally validated an easy-to-use prognostic model that may be used to risk-stratify monitoring for leflunomide toxicity and to make informed choices about risks when choosing treatments.
Keyphrases
  • clinical practice
  • oxidative stress
  • electronic health record
  • big data
  • human health
  • risk assessment